Release Date: 09/02/10 15:08 Summary: 2009 Financial Results - Preliminary Unaudited Estimates Price Sensitive: Yes Download Document 55.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%